• Welcome to Renmin Hospital of Wuhan University
  • 网站首页 中文版 English Francaise
  • 谢颂平 心胸外
    主任医师,副教授,硕士生导师,东院胸外科党支部书记
    A+ A-
    导师介绍

    姓名 谢颂平
    出生年月 1983.04
    单位 武汉大写人民医院胸外科
    所属学科 胸外科
    职务、职称及头衔 主任医师,副教授,硕士生导师,东院胸外科党支部书记
    E-mail songping0428@126.com
    联系方式 13871110636
    研究方向 CXCR4;急性肺损伤;胸部肿瘤的外科治疗
    个人简介
    擅长单孔胸腔镜下肺叶切除术、肺段切除术和袖式肺叶切除(每年开展的单孔胸腔镜手术全院第一);熟练开展全腔镜食管癌切除术,采用结肠代食管术、残胃代食管术治疗食管烧伤、食管癌复发、合并有胃部手术史的食管癌等复杂食管疾病。广泛开展局部晚期肺癌、局部晚期食管癌新辅助治疗后的微创化治疗,取得较好的疗效。熟练开展胸腔镜下纵隔肿瘤切除术、微创漏斗胸和鸡胸矫正术等。以第一作者或通讯作者身份共发表58篇(SCI 20篇,其中二区文章8篇;统计源文章38篇,其中中华类文章14篇,教学类论文6篇);主持国家自然科学基金两项(面上项目1项,青年项目1项),省、校级项目四项;获省科技进步奖一等奖一项,科技成果推广奖二等奖一项。
    学术任职与荣誉
    湖北省科学技术协会委员;湖北省微循环学会胸部微创外科青年委员会主任委员;中国抗癌协会食管癌专业委员会青年委员;中国抗癌协会康复会食管癌委员会委员,中国康复医学会外科快速康复专业委员会委员,国家自然科学基金评审专家,武汉市市级临床重点专科评审专家库成员,《中国胸心血管外科临床杂志》青年编委,《临床外科杂志》编委,《实用心脑血管病杂志》青年编委。2021 年东湖高新区“好医生” 称号获得者;2022年“武汉英才”称号获得者。
    教育履历
    1. 2012-09至2016-12,武汉大学,胸心外科学,博士
    2. 2007-09至2009-06,武汉大学,胸外科学,硕士
    3. 2002-09至2007-06,武汉大学,临床医学,学士
    工作履历
    1. 2022/11-至今,武汉大学,人民医院胸外科,主任医师
    2. 2019/11-至今,武汉大学,人民医院胸外科,副教授
    3. 2017/12-2022/11,武汉大学,人民医院胸外科,副主任医师
    4. 2012/06-2017/11,武汉大学,人民医院胸外科,主治医师
    5. 2009/9-2012/05,武汉大学,人民医院胸外科,住院医师
    成果获奖
    1.《结肠代食管手术技术创新及临床推广应用》获湖北省科技成果奖二等奖
    2.《肺移植缺血再灌注损伤机制及临床关键技术创新》获湖北省科技进步奖一等奖
    代表性论著
    1. Hui Liang(#), Gaoli Liu(#), Wenhui Zeng(#), Qinglu Fan, Zhihao Nie, Haifeng Hu, Renquan Zhang,Songping Xie. (2023). MEGF6 prevents sepsis-induced acute lung injury in mice,123:110727.
    2. Zhang RenQuan(#); Liang Hui(#); Liu GaoLi(#); Jiang WanLi; Tang Zheng; Fan QingLu; Nie ZhiHao; Hu HaiFeng; Kang GanJun;Xie SongPing. (2023). Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner. International immunopharmacology, 120, 110369.
    3. Wei ZiMeng(#); Zeng XinRuo(#); Lei YuFei; He HengJing; Jamal Muhammad; Zhang ChengJie; Tan HaiYan;Xie SongPing; Zhang QiuPing. (2022). TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer. International immunopharmacology, 110, 108999.
    4. Liu GaoLi; Wang Xin; Hu HaiFeng; Nie ZhiHaol; Ming Wei; Long XingLin; Zhang WenHan; Zhang XingHua; Huang Jie; Jiang WanLi;Xie SongPing. (2022). The Application of Two-Stage Operation for High-Risk Patients with Oesophageal Cancer Following Gastrectomy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 26(10), 2033–2040.
    5. Jiang WL(#), Zhao KC(#), Yuan W(#), Zhou F(#), Song HY, Liu GL, Huang J, Zou JJ(*), Zhao B(*),Xie SP(*). MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via Inactivating Cab39/AMPK α Pathway. Oxid Med Cell Longev. 2020, 2020:8822361. doi: 10.1155/2020/ 8822361.
    6. Wen Yuan(#), Heng-Ya Song(#), Jie Xiong, Wan-li Jiang, Gan-Jun Kang, Jie Huang(*),Song-Ping Xie(*). Placenta‑derived mesenchymal stem cells ameliorate lipopolysaccharide‑induced inflammation in RAW264.7 cells and acute lung injury in rats. Molecular Medicine Reports, 2020, 22: 1458-1466.
    7.Xie S(#), Liu G(#), Huang J, Hu HB, Jiang W*. miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4. J Cell Physiol. 2019, 234: 14050–14057.
    8. Wang M#,Xie S#, Yuan W, Xie T, Jamal M, Huang J, Yin Q, Song H, Zhang Q*. Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer. Int J Oncol. 2019, 55(6):1349-1360.
    9. Wu Y#, Jamal M, Xie T, Sun J, Song T, Yin Q, Li J, Pan S, Zeng X,Xie S*, Zhang Q*. Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer. Cancer Sci. 2019, 110(9):2734-2747.
    10. Zeng W#, Cao Y#, Jiang W, Kang G, Huang J,Xie S*. Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury. J Pharmacol Sci. 2019, 140(1):14-19.
    11. Zeng WH#, Jiang WL#, Kang GJ, Zhang XH, Fan GH, Geng Q,Xie SP*, Huang J*. Colon Interposition for Corrosive Esophageal Stricture: Single Institution Experience with 119 Cases. Curr Med Sci. 2019, 39(3): 415-418.
    12. Zhang Y#, Jiang WL#, Yang JY, Huang J, Kang G, Hu HB,Xie S*. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. J Cell Physiol. 2019, 234 (10): 18679-18687.
    13. Wen Yuan(#),Songping Xie(#), Meng Wang, Shan Pan, Xiaoxing Huang, Meng Xiong, Rui-jing Xiao, Jie Xiong, Qiu-ping Zhang, Liang Shao*. Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer. Onco Targets Ther. 2018, 11:1683-1695.
    Name Songping Xie
    Date of birth April, 1983
    Department Department of thoracic surgery, Renmin Hospital, Wuhan University.
    Title Chief physician, associate Professor of medicine, master tutor, Secretary of the Party branch
    Email songping0428@126.com
    TEL 13871110636
    Research Direction
    CXCR4; Acute lung injury; Surgical treatment of thoracic cancer.
    Personal Profile
    He is mainly engaged in the diagnosis and treatment of diseases of thoracic surgery,and has been awarded 2 items for the National Natural Science Foundation, 4 items from the provincial science and Technology Department and the Provincial Health Department. He has Obtain one Fisrt Class Prizes of The Provincial Scientific and Technological Progress Award,one Second Class Prizes of The Provincial Award for transfer of scientific and technological achievements. Besides,there are more than 58 articles, including 20 SCI papers. At present, there are 4 Masters studying with him.
    Selected Publications
    1. Hui Liang(#), Gaoli Liu(#), Wenhui Zeng(#), Qinglu Fan, Zhihao Nie, Haifeng Hu, Renquan Zhang,Songping Xie. (2023). MEGF6 prevents sepsis-induced acute lung injury in mice,123:110727.
    2. Zhang RenQuan(#); Liang Hui(#); Liu GaoLi(#); Jiang WanLi; Tang Zheng; Fan QingLu; Nie ZhiHao; Hu HaiFeng; Kang GanJun;Xie SongPing. (2023). Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner. International immunopharmacology, 120, 110369.
    3. Wei ZiMeng(#); Zeng XinRuo(#); Lei YuFei; He HengJing; Jamal Muhammad; Zhang ChengJie; Tan HaiYan;Xie SongPing; Zhang QiuPing. (2022). TTYH3, a potential prognosis biomarker associated with immune infiltration and immunotherapy response in lung cancer. International immunopharmacology, 110, 108999.
    4. Liu GaoLi; Wang Xin; Hu HaiFeng; Nie ZhiHaol; Ming Wei; Long XingLin; Zhang WenHan; Zhang XingHua; Huang Jie; Jiang WanLi;Xie SongPing. (2022). The Application of Two-Stage Operation for High-Risk Patients with Oesophageal Cancer Following Gastrectomy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 26(10), 2033–2040.
    5. Jiang WL(#), Zhao KC(#), Yuan W(#), Zhou F(#), Song HY, Liu GL, Huang J, Zou JJ(*), Zhao B(*),Xie SP(*). MicroRNA-31-5p Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via Inactivating Cab39/AMPK α Pathway. Oxid Med Cell Longev. 2020, 2020:8822361. doi: 10.1155/2020/ 8822361.
    6. Wen Yuan(#), Heng-Ya Song(#), Jie Xiong, Wan-li Jiang, Gan-Jun Kang, Jie Huang(*),Song-Ping Xie(*). Placenta‑derived mesenchymal stem cells ameliorate lipopolysaccharide‑induced inflammation in RAW264.7 cells and acute lung injury in rats. Molecular Medicine Reports, 2020, 22: 1458-1466.
    7.Xie S(#), Liu G(#), Huang J, Hu HB, Jiang W*. miR-210 promotes lung adenocarcinoma proliferation, migration, and invasion by targeting lysyl oxidase-like 4. J Cell Physiol. 2019, 234: 14050–14057.
    8. Wang M#,Xie S#, Yuan W, Xie T, Jamal M, Huang J, Yin Q, Song H, Zhang Q*. Minichromosome maintenance protein 10 as a marker for proliferation and prognosis in lung cancer. Int J Oncol. 2019, 55(6):1349-1360.
    9. Wu Y#, Jamal M, Xie T, Sun J, Song T, Yin Q, Li J, Pan S, Zeng X,Xie S*, Zhang Q*. Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer. Cancer Sci. 2019, 110(9):2734-2747.
    10. Zeng W#, Cao Y#, Jiang W, Kang G, Huang J,Xie S*. Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury. J Pharmacol Sci. 2019, 140(1):14-19.
    11. Zeng WH#, Jiang WL#, Kang GJ, Zhang XH, Fan GH, Geng Q,Xie SP*, Huang J*. Colon Interposition for Corrosive Esophageal Stricture: Single Institution Experience with 119 Cases. Curr Med Sci. 2019, 39(3): 415-418.
    12. Zhang Y#, Jiang WL#, Yang JY, Huang J, Kang G, Hu HB,Xie S*. Downregulation of lysyl oxidase-like 4 LOXL4 by miR-135a-5p promotes lung cancer progression in vitro and in vivo. J Cell Physiol. 2019, 234 (10): 18679-18687.
    13. Wen Yuan(#),Songping Xie(#), Meng Wang, Shan Pan, Xiaoxing Huang, Meng Xiong, Rui-jing Xiao, Jie Xiong, Qiu-ping Zhang, Liang Shao*. Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer. Onco Targets Ther. 2018, 11:1683-1695.